Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 541,158 | 177,668 | 72,406 | 126,971 | 125,007 |
| Receivables | 157,046 | N/A | N/A | N/A | 1,859 |
| Inventories | 44,233 | 9,807 | 1,659 | N/A | N/A |
| Other current assets | 5,613 | 146,956 | 2,462 | 3,537 | 34,620 |
| TOTAL | $767,479 | $343,009 | $84,433 | $145,477 | $161,486 |
| Non-Current Assets | |||||
| PPE Net | 10,108 | 5,840 | 6,660 | 12,773 | 10,772 |
| Intangibles | 3,563 | 3,563 | 3,563 | 3,563 | 3,563 |
| Other Non-Current Assets | 60,499 | 56,515 | 4,811 | 798 | 2,664 |
| TOTAL | $74,170 | $65,918 | $15,034 | $17,134 | $16,999 |
| Total Assets | $841,649 | $408,927 | $99,467 | $162,611 | $178,485 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,201 | 25,985 | 15,294 | 15,714 | 20,583 |
| Accrued Expenses | 130,452 | 86,788 | 17,548 | 9,050 | 28,022 |
| Other current liabilities | N/A | 2,196 | 419 | 3,631 | 6,879 |
| TOTAL | $145,653 | $114,969 | $33,261 | $28,395 | $56,376 |
| Non-Current Liabilities | |||||
| Long Term Debt | 74,481 | 73,663 | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 892 |
| Other Non-Current Liabilities | 340,541 | 115,081 | 104,867 | 103,797 | 102,537 |
| TOTAL | $415,022 | $188,744 | $104,797 | $103,681 | $102,755 |
| Total Liabilities | $560,675 | $303,713 | $138,058 | $132,076 | $159,131 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,794 | 70,624 | 69,260 | 60,142 | 51,147 |
| Common Shares | 7 | 7 | 7 | 6 | 5 |
| Retained earnings | -762,754 | -894,998 | -984,831 | -775,492 | -537,322 |
| Other shareholders' equity | -270 | -558 | -282 | -2,039 | -1,803 |
| TOTAL | $280,974 | $105,214 | $-38,591 | $30,535 | $19,354 |
| Total Liabilities And Equity | $841,649 | $408,927 | $99,467 | $162,611 | $178,485 |